AG-183 is a potent protein tyrosine kinase (PTK) inhibitor. AG-183 inhibits the volume-dependent release of [3H]taurine in a dose-dependent manner. AG-183 markedly reduces cellular tyrosyl phosphorylation level. AG-183 inhibits both basal and EGF-induced human bone cell proliferation.